Analytic Biotech Systems

A pathogen detection system that accurately produces res...


(

Private Fundraise

This company may be interested in raising funds from accredited investors. You must Request Access to see more information about this company.

Request Access 9

THE NEXT GENERATION OF RAPID 
MICROBIAL TESTING TECHNOLOGY
The MuScan® Technology

The MuScan® technology is an LED-based optical scanning protocol that allows for rapid, automated, full-field scanning of a surface containing fluorescently stained cells, thus allowing for a fast and sensitive detection of micro-organisms. Samples are tested for the presence of specific pathogens by utilizing one or more assays (“test kits”) developed for Analytic by Innosieve, B.V. 

THE NEXT GENERATION OF RAPID 
MICROBIAL TESTING TECHNOLOGY
Speed, Accuracy, and Recurring Revenue

The MuScan® Technology provides unprecedented speed and accuracy of pathogen testing through the use of a highly efficient, simple to use, and cost-effective technology.  

This competitive advantage has already created significant demand in our target markets. We will initially generate revenue through sales or lease of the MuScan® units, with recurring revenue generated from the ongoing sale and use of test kits. 

THE NEXT GENERATION OF RAPID
MICROBIAL TESTING TECHNOLOGY

MuScan® Benefits

THE NEXT GENERATION OF RAPID
MICROBIAL TESTING TECHNOLOGY

Target Markets


Cannabis Labs and Cultivators, Petroleum Producers, and the Maritime Industries, including Cruise Lines, the Coast Guard and other regulatory and enforcement agencies.

THE NEXT GENERATION OF RAPID 
MICROBIAL TESTING TECHNOLOGY

Problems and Solutions​

THE NEXT GENERATION OF RAPID
MICROBIAL TESTING TECHNOLOGY

Our Markets: Cannabis

Marijuana is a derivative of cannabis. Until marijuana is legalized at the Federal level, there is a prohibition against shipping marijuana or products containing marijuana across state lines. 

Currently, marijuana is legal in 33 states and in Canada, but must be tested for certain pathogens.  The testing regulations vary slightly from state to state, but only six specific pathogen tests are needed to meet 98% of U.S. market demands.  By providing these six tests, Analytic Biotech Systems will be a market leader in cannabis throughout North America.

THE NEXT GENERATION OF RAPID
MICROBIAL TESTING TECHNOLOGY

Our Markets: Petroleum

The Petroleum industry is concerned about the presence of certain bacteria in both producing and exploratory wells. Rapid testing for the target bacteria is economically attractive to this industry as wells can be damaged or closed due to bacterial contamination.

Analytic Biotech Systems has allied itself with Multi-Chem Group, LLC – a Halliburton service company, to bring the first MuScan® unit to its lab to inaugurate  Analytic’s participation in this industry.

THE NEXT GENERATION OF RAPID
MICROBIAL TESTING TECHNOLOGY

Our Markets: Maritime

The operation of  commercial shipping in international waters is regulated by the International Maritime Organization (IMO) under the umbrella of the United Nations. The U.S. Coast Guard and Transport Canada are charged with enforcing IMO regulations and developing monitoring systems to better carry out their duties.

An easy-to-use, rapid, and accurate microbial testing system will assist the IMO to carry out its mandate.  Commercial Shipping and Cruise lines will also benefit from the MuScan® technology as it simplifies their compliance with IMO regulations and thus avoid sanctions.

THE NEXT GENERATION OF RAPID
MICROBIAL TESTING TECHNOLOGY

Analytic Biotech Systems Key Personnel

The Business Plan area is locked. You must Request Access to this company to see more information including the Business Plan.


Request Access

N

No updates yet.




%

No backers yet.




Quick Signup TBD

You must have an account to do this!


the startups.com platform

Copyright © 2019 Startups.com. All rights reserved.

Fundable is a software as a service crowdfunding platform. Fundable is not a registered broker-dealer and does not offer investment advice or advise on the raising of capital through securities offerings. Fundable does not recommend or otherwise suggest that any investor make an investment in a particular company, or that any company offer securities to a particular investor. Fundable takes no part in the negotiation or execution of transactions for the purchase or sale of securities, and at no time has possession of funds or securities. No securities transactions are executed or negotiated on or through the Fundable platform. Fundable receives no compensation in connection with the purchase or sale of securities.